#

HEK ARID2 KO11

HEK ARID2 KO11

Availability: 3-4 weeks

Organism: Human

Tissue: kidney

Model: Genetically modified; immortalised non-cancer cells

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jessica Downs, Hugang Feng

Institute: The Institute of Cancer Research

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: HEK ARID2 KO11
  • Parental cell: HEK293TN
  • Clone: 11 (also called A11)
  • Organism: Human
  • Gender: Female
  • Tissue: kidney
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Genetically modified; immortalised non-cancer cells
  • Model description: ARID2 knockout
  • Crispr: Yes
  • Conditional: No
  • Products or characteristics of interest: Gene loss-of-function, chromatin-remodelling, DNA damage, cell cycle response, regulation of t-cell-mediated cell killing.
  • Description: HEK293TN cell line knockout for ARID2 knockout (clone 11, also called A11). This cell line was generated using CRISPR-Cas9 engineering to create a loss of function mutation in the indicated subunit of the SWI/SNF chromatin remodelling complex. The cell line was validated using Sanger sequencing, immunofluorescence, and proteomic analysis.
  • Application: Chromatin remodelling biology studies
  • Biosafety level: 1

Applications

  • Application: Chromatin remodelling biology studies

Handling

  • Format: Frozen
  • Growth medium: DMEM + 10%FBS + 1% Penicillin/Streptomycin
  • Temperature: 37C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Cultured in antibiotics: 1% Penicillin/Streptomycin
  • Mycoplasma free: Yes
  • Str profiling: See Cellosaurus profile of parental cell line

References

  • Unpublished